Literature DB >> 33900080

Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design.

Laura Zanetti-Polzi1, Micholas Dean Smith2, Chris Chipot3,4, James C Gumbart5, Diane L Lynch5, Anna Pavlova5, Jeremy C Smith2,6, Isabella Daidone7.   

Abstract

The catalytic reaction in SARS-CoV-2 main protease is activated by a proton transfer (PT) from Cys145 to His41. The same PT is likely also required for the covalent binding of some inhibitors. Here we use a multiscale computational approach to investigate the PT thermodynamics in the apo enzyme and in complex with two potent inhibitors, N3 and the α-ketoamide 13b. We show that with the inhibitors the free energy cost to reach the charge-separated state of the active-site dyad is lower, with N3 inducing the most significant reduction. We also show that a few key sites (including specific water molecules) significantly enhance or reduce the thermodynamic feasibility of the PT reaction, with selective desolvation of the active site playing a crucial role. The approach presented is a cost-effective procedure to identify the enzyme regions that control the activation of the catalytic reaction and is thus also useful to guide the design of inhibitors.

Entities:  

Year:  2021        PMID: 33900080     DOI: 10.1021/acs.jpclett.1c00425

Source DB:  PubMed          Journal:  J Phys Chem Lett        ISSN: 1948-7185            Impact factor:   6.475


  5 in total

1.  A computational study of cooperative binding to multiple SARS-CoV-2 proteins.

Authors:  Jianing Li; Kyle T McKay; Jacob M Remington; Severin T Schneebeli
Journal:  Sci Rep       Date:  2021-08-11       Impact factor: 4.996

2.  An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study.

Authors:  Snehasis Banerjee
Journal:  Biophys Chem       Date:  2020-11-28       Impact factor: 2.352

3.  Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro.

Authors:  Son Tung Ngo; Trung Hai Nguyen; Nguyen Thanh Tung; Binh Khanh Mai
Journal:  RSC Adv       Date:  2022-01-28       Impact factor: 3.361

4.  Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor.

Authors:  Jens Glaser; Ada Sedova; Stephanie Galanie; Daniel W Kneller; Russell B Davidson; Elvis Maradzike; Sara Del Galdo; Audrey Labbé; Darren J Hsu; Rupesh Agarwal; Dmytro Bykov; Arnold Tharrington; Jerry M Parks; Dayle M A Smith; Isabella Daidone; Leighton Coates; Andrey Kovalevsky; Jeremy C Smith
Journal:  ACS Pharmacol Transl Sci       Date:  2022-04-04

5.  Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics.

Authors:  Hani A Alhadrami; Ahmed M Sayed; Ahmed M Sharif; Esam I Azhar; Mostafa E Rateb
Journal:  Molecules       Date:  2021-05-01       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.